文章基本信息

标题：Recent Update on Neurosurgical Management of Brain Metastasis
本地全文：下载
作者：Jihwan Yoo ; Hun Ho Park ; Seok-Gu Kang 等
期刊名称：Brain Tumor Research and Treatment
印刷版ISSN：2288-2405
出版年度：2022
卷号：10
期号：3
页码：164-171
DOI：10.14791/btrt.2022.0023
语种：English
出版社：The Korean Brain Tumor Society and The Korean Society for Neuro-Oncology
摘要：Brain metastasis (BM), classified as a secondary brain tumor, is the most common malignant central nervous system tumor whose median overall survival is approximately 6 months. However, the survival rate of patients with BMs has increased with recent advancements in immunotherapy and targeted therapy. This means that clinicians should take a more active position in the treatment paradigm that passively treats BMs. Because patients with BM are treated in a variety of clinical settings, treatment planning requires a more sophisticated decision-making process than that for other primary malignancies. Therefore, an accurate prognostic prediction is essential, for which a graded prognostic assessment that reflects next-generation sequencing can be helpful. It is also essential to understand the indications for various treatment modalities, such as surgical resection, stereotactic radiosurgery, and whole-brain radiotherapy and consider their advantages and disadvantages when choosing a treatment plan. Surgical resection serves a limited auxiliary function in BM, but it can be an essential therapeutic approach for increasing the survival rate of specific patients; therefore, this must be thoroughly recognized during the treatment process. The ultimate goal of surgical resection is maximal safe resection; to this end, neuronavigation, intraoperative neuro-electrophysiologic assessment including evoked potential, and the use of fluorescent materials could be helpful. In this review, we summarize the considerations for neurosurgical treatment in a rapidly changing treatment environment.
关键词：Brain neoplasms;Neurosurgery;Neoplasm grading;Evoked potentials;Fluorescein